CRISCuris, Inc.

$14M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-15.5% YoY

Gross Profit

$3M94.7% margin

Operating Income

-$5M-186.9% margin

Net Income

-$6M-215.6% margin

EPS (Diluted)

$-3.59

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$631,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$42M

Stockholders' Equity

-$4M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-15.5%
Gross Profit	$3M	$3M	-15.8%
Operating Income	-$5M	-$7M	+27.8%
Net Income	-$6M	-$8M	+26.0%

Revenue Segments

Gross Royalty Revenue

$3M100%

CRIS Q4 2018 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena